A Worldwide Milestone in Cell Analysis - 40 Years of Flow Cytometry
GORLITZ, Germany, June 18 /PRNewswire/ -- 2009 is the year of the 40th
anniversary since the introduction of the worldwide first fluorescence based
flow cytometer - the ICP 11.
Today, the German biotechnology company celebrates this anniversary at
the Saxonian State Vineyard Castle Wack...
Amnis Launches New ImageStreamX Imaging Flow Cytometer
SEATTLE, May 8 /PRNewswire/ -- Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced the launch of the new ImageStreamX imaging flow
cytometer. The new instrument - the second generation of the patented ImageStream(R) technology - combines the speed, sensitivity, and...
Accuri Cytometers Adds Automation to Its Revolutionary C6 Flow Cytometer(R) System With Commercial Launch of CSampler(TM)
-Accuri CSampler Provides Simple, Reliable, Easy-to-Use and Affordable Automation for the C6 Flow
-Accuri Announces Opening of European Headquarters and Operations-
-See CSampler at the Accuri Booth at Immunology 2009 and at the American Society of Microbiology 109th A...
Brooks Instrument's New Mass Flow Controller Series Is Immune to Pressure and Temperature Fluctuations
Brooks Instrument, a world-leading flow
measurement and control provider, is pleased to release the B-Series mass flow
controller, a totally new family of mass flow
products designed to be insensitive to fluctuations in pressure and temperature. Built on a standard 1.125-inch wide platform with a...
VirtualScopics Achieves Operating Cash Flow Breakeven in the Fourth Quarter 2008; Reports Record 2008 Revenue and Gross Profit
4th quarter gross profit grows by nearly 90%, operating loss reduced by 73%
ROCHESTER, N.Y., Feb. 25 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP ), a leading provider of quantitative imaging for clinical trials, announced today that revenues for the fourth quarter of 2008 w...
Cord Blood America Restructures Debt; Projects to be Cash Flow Positive
SANTA MONICA, Calif., Feb. 25 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internati...
MaxCyte Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
Technology enhances biological activity (regenerative potential) of stem cells and accelerates development of proprietary enhanced therapeutics
GAITHERSBURG, Md., Feb. 17 /PRNewswire-USNewswire/ -- MaxCyte announces today the introduction of its GT(TM) Flow
Transfection System at the 4th Annu...
ThalesNano Flow Reactor Realizes Microwave Speed With Scale-up Ability
BUDAPEST, Hungary, LONDON and PRINCETON, N.J., Feb. 10 /PRNewswire/ -- ThalesNano today announced a big step forward in the evolution of flow
chemistry with the independent publication of results that prove that flow
chemistry can match microwave chemistry in terms of speed, but with the ability t...
ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
Kristin Lucas, ClearTrial Senior Director of Clinical Services, will lead a panel of top pharmaceutical financial experts in discussing "Methodologies for Managing Cash Flow
and Accruals" at the CBI Forecasting & Budgeting conference. The panel will demonstrate practical ways to ga...
The New MACSQuant(TM) Analyzer Combines Cell Enrichment and Flow Cytometry
BERGISCH GLADBACH, Germany, January 16 /PRNewswire/ -- Miltenyi Biotec
announces the worldwide release of the MACSQuant(TM) Analyzer, a novel and
cytometer for multiparameter cell analysis. With this instrument
launch Miltenyi Biotec broadens the product portfolio of the cell anal...
The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System
The HeartAssist 5™ Pediatric VAD will be introduced for the first time in the U.S. at the 16th annual meeting of the International Society for Rotary Blood Pumps (ISRBP) in Houston on Oct. 2-4.
HOUSTON (Business Wire EON) September 30, 2008 -- The Modern DeBakey...
World Leader in Bench Top Flow Chemistry Instruments ThalesNano, Inc. Introduces an 'Industry First' Seminar Series
BUDAPEST, Hungary, LONDON and PRINCETON, N.J., Sept. 24 /PRNewswire/ --
ThalesNano Inc. has announced that commencing in October, it will hold a
series of unique seminars entitled, "Experience Your Chemistry in Flow".
"Flow chemistry has already had a dramatic impact on how chemistry is
World Leader in Bench-Top Flow Chemistry Instruments ThalesNano, Inc. Closes Funding Round
BUDAPEST, Hungary and LONDON and PRINCETON, New Jersey and SAN DIEGO,
California, September 8 /PRNewswire/ --
- Investment to be Used to Accelerate R&D for Continuous Process
Chemistry Technologies and for Further Global Expansion
ThalesNano Inc. announced today the closing of an investmen...
Tree branching key to efficient flow in nature and novel materials
DURHAM, N.C. Nature, in the simple form of a tree canopy, appears to provide keen insights into the best way to design complex systems to move substances from one place to another, an essential ingredient in the development of novel "smart" materials.
Duke University engineers believe that an ...
Device That Clears Debris From Artery Aids Blood Flow in PCI
Better clinical results with Export Aspiration Catheter hold up at one year
CHICAGO, March 30 /PRNewswire/ -- Use of a special catheter that sucks
out, or aspirates, bits of plaque and blood clot that break loose during
percutaneous coronary intervention (PCI) significantly enhances blood flow
Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008
CTI to present at 2008 BIO CEO & Investor conference at the Waldorf-Astoria in New York on Tuesday, February 12 at 1:15 PM (Eastern)
NEW YORK, Feb. 12 /PRNewswire-FirstCall/ -- BIO CEO & Investor
conference -- James A. Bianco, M.D., President and CEO of Cell
Therapeutics, Inc. (CTI) (Nasd...
Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007
Radi Medical Systems Sponsors Case Review with Drs. Morton Kern, Nico Pijls, Augusto Pichard
UPPSALA, Sweden and WILMINGTON, Mass., Oct. 19 /PRNewswire/ -- The use
of fractional flow
reserve (FFR) for optimizing patient outcomes is the
topic of several sessions at this...
New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
HAYWARD, Calif., Oct. 11 /PRNewswire/ -- Guava Technologies today
launched a new corporate website with an infrastructure focused around its
main audiences: Life Scientists, Flow
Cytometrists, and Clinicians. With flow
cytometry being an essential tool for cell analysis, Guava
DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow
Company Provides Fourth Quarter 2008 and Full Year 2009 Earnings Guidance
WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCall/ -- DuPont, (NYSE: DD ) today announced further actions to address current market challenges and strengthen the company's competitiveness in 2009, including con...
Nanotubes go with the flow
Carbon nanotubes are attractive candidates for use as the active elements in the next generation of electronic devices. However, it has proven incredibly difficult to align nanotubes within device architectures. Most of the approaches for lining up carbon nanotubes reported until now are only appl...
Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast
...s, such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow
guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) and Forward-Looking IVUS systems and catheters. Curre...
Microbix Sales Grow 22% For Nine Months
... manufacturing facility is fully operational, cash flow
is improving and the opportunity to create shareho...r corporate objective is to be profitable and cash flow
positive in 2010. With the additional capacity we ...r the third quarter 2009 compared to negative cash flow
$ 1,079,492 in the same period in 2008.
A lower ...
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
...implanted in the inferior vena cava and are designed to catch clot material to prevent it from reaching the lungs, while allowing blood to continue to flow
normally. Patients at high risk for pulmonary embolism are typically patients undergoing a significant surgical procedure, trauma patients or patients...
PDI Reports 2009 Second Quarter Financial Results
...iabilities $28,257 $41,929
Total stockholders' equity $97,435 $107,107
Selected Cash flow
June 30, June 30,
ERT Reports Second Quarter 2009 Results
...ings were $35.7 million in the second quarter of 2009 compared to $49.0 million a year ago and $31.2 million for the first quarter of 2009.
from operations in the second quarter of 2009 was $10.0 million compared to $10.4 million a year ago and $9.1 million in the first quarter of 2009.
Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
The following table presents condensed consolidated cash flow
data for the six months ended June 30, 2009 and June 30, 2008:
...o Pharmaceuticals Holdings Inc.
Condensed Consolidated Cash flow
Caliper Life Sciences Reports Second Quarter 2009 Results
...s significantly reduced cash utilization, accelerating our path toward cash flow
breakeven," added Hrusovsky.
The Company proj...r's expectations regarding future cash flows and its ability to attain cash flow
breakeven performance, its ability to achieve positive earnings before inte...
NIST scientists study how to stack the deck for organic solar power
...polymer network should ideally all reach the bottom of the film while the fullerene channels should ideally all reach the top, so that electricity can flow
in the correct direction out of the device. However, if barriers of fullerenes form between the polymers and the bottom edge of the film, the cell's e...
Sanofi-aventis Announces Second Quarter 2009 Results
...n a reported basis
Strong cash flow
from operating activities in the first half, at eu...e no cash impact for the Group
Strong cash flow
from operating activities in the first half of 2009
Operating cash flow
before changes in working capital totaled euro 5,3...
Cynosure Reports Second Quarter 2009 Financial Results
...pense savings of between $14 million and $18 million in 2009. We were cash flow
neutral in the second quarter and maintained our cash, cash equivalents and...d. "We continue to carefully manage our business, with the goal to be cash flow
neutral for the year. In addition, we are excited about our long-term pros...
NeoGenomics Reports Second Quarter 2009 Results
...e fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow
cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, ...
PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2
...cts tumor volume and changes in hearing and word recognition among patients with NF2. The trial will also assess the effects of PTC299 on tumor blood flow
and VEGF-related proteins. The study will be conducted at the Massachusetts General Hospital in Boston, Massachusetts.
"We are excited to ra...
Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.
...s for the first half of 2009.
Free cash flow
(defined on page 6) for the second quarter of 2009...cash provided by operating activities to free cash flow
is on page 8.
Highlights in the second qu...s of $110 million for 2009, resulting in free cash flow
in excess of $300 million for the year.
Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
... have the opportunity to develop and commercialize them on behalf of both companies. This agreement will allow us to realize positive short-term cash flow
and at the same time maintain an interest in the significant upside potential of the anti-VEGF program. This agreement fits very nicely with our anno...
Neogen Reports 16% Increase in Revenues
...ceed our percentage growth in revenue for the fourth quarter as we continue to emphasize cost reduction and productivity improvements."
from operations for FY 2009 improved $3.1 million when compared to FY 2008 with much of the improvement coming in the May quarter as a result of impro...
Schering-Plough Reports Financial Results for 2009 Second Quarter
...ases. In our industry, long-term strength comes from creating a continuous flow
of new innovations. We are proud that we have created such a strong and pr...ength, the company highlighted its strong R&D engine and steady product flow
as a special asset at a time when R&D innovation in the industry is so ...
Heart disease: Research off the beating patch
...s a means to deliver living heart cells into a diseased heart, the group has already shown that the patch improves left ventricular function and blood flow
when implanted into damaged heart muscle in a rat model of myocardial infarction.
Dr. Goldman believes that the construct developed in his lab prov...
China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
...55.0 million. In fiscal 2009, China-Biotics
generated $23.1 million in cash flow
from operations and recorded $17.5
million in capital expenditures, primari... $70,824,041 $64,310,448
Supplemental of cash flow
Interest paid $808,219 ...
Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
...e Statement, the Balance Sheet, the Statement of change in
Equity, the Cash flow
Statement and the Cap table are presented below.
Income Statement (1...EUR) compared to 6,3m DKK (0,8m EUR) in 2008.
Balance Sheet and Cash flow
As at June 30 2009, the Company had total assets of 234,6m DKK (31,5...
Accuri Cytometers Completes $4 Million Series D Financing
...pport the rapid market acceptance of the Accuri C6 flow
Cytometer(R) System, a revolutionary product designed to bring the power of flow
cytometry analysis to the laboratory of every life...biomedical researchers in their own labs, Accuri's flow
cytometer is a full-featured bench-top cell analys...